ArticleInternational journal of surgery (London, England)2026
Global, regional, and national burden of gallbladder and biliary tract cancer from 1990 to 2021 and projections to 2050: a systematic analysis integrating the Global Burden of Disease 2021 and Mendelian randomization.
Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gallbladder and biliary tract cancer (GBTC) imposes a growing global public health burden, with significant socioeconomic disparities. We assessed trends from 1990 to 2021, quantified inequalities, projected future burden, and evaluated the causal role of high body mass index (BMI) using Mendelian randomization (MR). Methods: Using Global Burden of Disease (GBD) 2021 data, we analyzed global/regional/national incidence, mortality, and disability-adjusted life years (DALYs) for GBTC. We decomposed drivers of burden changes, quantified cross-country inequalities with slope index of inequality, concentration index, projected trends to 2050 via Bayesian age-period-cohort modeling, and conducted two-sample MR to test BMI-GBTC causality. Results: Global GBTC prevalent cases increased by 142% (1990-2021), while age-standardized rates (ASRs) rose modestly (incidence EAPC = 0.97; mortality EAPC = 0.47). Burden was highest in high-socio-demographic index (SDI) regions, but low-SDI regions exhibited rising mortality and DALYs. Decomposition identified population growth as the primary burden driver across all SDI strata. Inequality analysis revealed persistent yet narrowing disparities. Projections indicated declining ASRs but rising absolute cases (+30% by 2050). MR confirmed a causal effect of elevated BMI on GBTC risk (OR = 1.0005 per unit BMI; 95% CI: 1.0000-1.0010; Conclusions: GBTC burden growth is predominantly fueled by demographic forces, with worsening trends in resource-limited regions. The causal link between high BMI and GBTC underscores the need for targeted obesity interventions. Equitable prevention strategies and improved healthcare access are critical to mitigate disparities, particularly in low-SDI settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.